Table 2.
Substrate | Enzyme | k obs (min −1 ) b | k rel c |
---|---|---|---|
Gli1 | ADAR1 R3D | 1.7 ± 0.2 | 1 |
ADAR1 R3D, G1007R | 0.07 ± 0.01 | 0.04 | |
ADAR1 R3D, K999N | 0.4 ± 0.1 | 0.2 | |
ADAR1 R3D, R892H | 0.3 ± 0.1 | 0.2 | |
ADAR1 R3D, Y1112F | 1.3 ± 0.2 | 0.7 | |
5-HT2c | ADAR1 R3D | 0.05 ± 0.01 | 1.0 |
ADAR1 R3D, G1007R | - | - | |
ADAR1 R3D, K999N | - | - | |
ADAR1 R3D, R892H | - | - | |
ADAR1 R3D, Y1112F | 0.04 ± 0.01 | 0.8 |
hGli1 and 5-HT2cR pre-mRNA substrate sequences are shown in Table S1. ADAR1 R3D reactions were carried out with 15 mM Tris–HCl pH 7.5, 26 mM KCl, 40 mM potassium glutamate, 1.5 mM EDTA, 0.003% (v/v) NP-40, 4% (v/v) glycerol, 0.5 mM DTT, 1 μg/mL yeast tRNA, and 0.16 U/μL RNAse inhibitor.
kobs was calculated by fitting fitting product formed at different time points to the equation: [P]t = α[1 −e−kobst] where [P]t is percent edited, α is the end point fitted to 95%, and kobs is the observed rate constant.
krel = kobs for mutant/kobs for ADAR1 R3D.